LAWRENCE, Mass., Dec. 18,
2014 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a
leading manufacturer of innovative dialysis products, today
announced that Jeffrey H. Burbank,
Chief Executive Officer and Matthew W.
Towse, Chief Financial Officer, will present at the 33rd
Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 15th at 12:00 p.m. PST.
A webcast of the event will be made available at
http://ir.nxstage.com at the time of the presentation.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of ESRD and acute kidney
failure. For more information on NxStage and its products, please
visit the Company's website at www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Examples of these forward-looking statements include
statements as to Messrs. Burbank and Towse's plans to present at
this conference. NxStage specifically disclaims any
obligation to update these forward-looking statements. These
forward-looking statements should not be relied upon as
representing NxStage's expectations or beliefs as of any date
subsequent to the date of this press release.
Contact:
Kristen K. Sheppard,
Esq.
Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-present-at-the-33rd-annual-jp-morgan-healthcare-conference-300011854.html
SOURCE NxStage Medical, Inc.